Related references
Note: Only part of the references are listed.Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma
Dana Holzinger et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Mature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encephalomyelitis
Pingxia Lu et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus
Mark E. Zafereo et al.
ORAL ONCOLOGY (2016)
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Lifang Zhang et al.
MOLECULAR CANCER (2015)
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status
Karen S. Anderson et al.
ORAL ONCOLOGY (2015)
Staging and treatment of oropharyngeal cancer in the human papillomavirus era
Matthew J. Ward et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy
Irene Casanova-Salas et al.
JOURNAL OF UROLOGY (2014)
Epidemiology of HPV-associated oropharyngeal cancer
Kristen B. Pytynia et al.
ORAL ONCOLOGY (2014)
Molecular mechanisms of HPV induced carcinogenesis in head and neck
Theodoros Rampias et al.
ORAL ONCOLOGY (2014)
Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma
Lei Jin et al.
MOLECULAR CANCER (2013)
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas
Mark W. Lingen et al.
ORAL ONCOLOGY (2013)
miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro
Laoighse Mulrane et al.
CLINICAL CANCER RESEARCH (2012)
Transforming Growth Factor beta1 Gene Variation Leu10Pro Affects Secretion and Function in Hepatic Cells
Xing Gu et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
TGF-β Signaling Pathway and Breast Cancer Susceptibility
Serena Scollen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Sergio A. Quezada et al.
IMMUNOLOGICAL REVIEWS (2011)
Cancer Burden in the HIV-Infected Population in the United States
Meredith S. Shiels et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Single-Nucleotide Polymorphisms Inside MicroRNA Target Sites Influence Tumor Susceptibility
Milena S. Nicoloso et al.
CANCER RESEARCH (2010)
Association of TGF-β1 Genetic Variants with HPV16-positive Oropharyngeal Cancer
Xiaoxiang Guan et al.
CLINICAL CANCER RESEARCH (2010)
Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci
Gillian K. Reeves et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
MicroRNA Binding-Site Polymorphisms as Potential Biomarkers of Cancer Risk
Rachel C. Blitzblau et al.
MOLECULAR DIAGNOSIS & THERAPY (2010)
Total Exposure and Exposure Rate Effects for Alcohol and Smoking and Risk of Head and Neck Cancer: A Pooled Analysis of Case-Control Studies
Jay H. Lubin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Association of p73 G4C14-to-A4T14 Polymorphism With Human Papillomavirus Type 16 Status in Squamous Cell Carcinoma of the Head and Neck in Non-Hispanic Whites
Xuemei Ji et al.
CANCER (2009)
Signaling cross-talk between TGF-beta/BMP and other pathways
Xing Guo et al.
CELL RESEARCH (2009)
Single Nucleotide Polymorphism at rs1982073:T869C of the TGFβ1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiotherapy
Xianglin Yuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS
Anil K. Chaturvedi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility
A. L. Teixeira et al.
PHARMACOGENOMICS JOURNAL (2009)
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6
Xiaohong Wang et al.
RNA (2009)
Elevated serum level and gene polymorphisms of TGF-beta 1 in gastric cancer
Xue Li et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2008)
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
TGFβ-SMAD signal transduction:: molecular specificity and functional flexibility
Bernhard Schmierer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas
AR Kreimer et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database
AL Carvalho et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway
P Nair et al.
JOURNAL OF VIROLOGY (2003)
Preoperative plasma levels of transforming growth factor beta1 (TGF-β1) strongly predict progression in patients undergoing radical prostatectomy
SF Shariat et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)